Bempedoic Acid + Ezetimibe
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Bempedoic Acid
bempedoic-acid - Ezetimibe
ezetimibe
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Nustendi 180mg/10mg tabletsESEUGBHK | 180 mg / 10 mg | DAIICHI SANKYO HONG KONG LIMITED |
| Bempedoic acid 180mg / Ezetimibe 10mg tabletsGB | 180 mg / 10 mg | Daiichi Sankyo UK Ltd |
| NexlizetUS | 180 mg / 10 mg | Esperion Therapeutics, Inc. |
| Bempedoic Acid and EzetimibeUS | 180 mg / 10 mg | Esperion Therapeutics, Inc. |
| ácido bempedoico + ezetimibaES | 180 mg / 10 mg | Daiichi Sankyo Europe Gmbh |
| 耐脂德膜衣錠TW | — | 台灣第一三共股份有限公司 |
| Nustendi F.C. TabletsTW | — | 台灣第一三共股份有限公司 |
| NEXLIZET bempedoic acid and ezetimibe 180 mg/10 mg tablet bottleAU | 180 mg / 10 mg | Seqirus Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- GB · NUSTENDI · 3 products · record
- US · Nexlizet · 1 products · record
- ES · NUSTENDI · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.